Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer
Background/Aims: Although EpCAM+CD44+ cells exhibit more stem-like properties than did EpCAM-CD44- cells, the specificity of EpCAM combined with CD44 in defining CSCs needs further improvement. Lgr5 is used as a biomarker to isolate cancer stem cells (CSCs) in colorectal cancer. However, it remains...
Main Authors: | Zhengwei Leng, Qinghua Xia, Jinhuang Chen, Yong Li, Jiqian Xu, Ende Zhao, Hai Zheng, Walden Ai, Jiangchuan Dong |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2018-03-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/488743 |
Similar Items
-
Clinical Significance of Stem Cell Biomarkers EpCAM, LGR5 and LGR4 mRNA Levels in Lymph Nodes of Colon Cancer Patients
by: Manar AbdelMageed, et al.
Published: (2021-12-01) -
Simulation and Stability Assessment of Anti-EpCAM Immunotoxin for Cancer Therapy
by: Seyed-Ali Hosseinian, et al.
Published: (2018-08-01) -
Absence of EpCAM in cervical cancer cells is involved in sluginduced epithelial‐mesenchymal transition
by: Xian Liu, et al.
Published: (2021-03-01) -
EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs
by: Joanna Macdonald, et al.
Published: (2018-01-01) -
EpCAM is critical for tumor proliferation and oxaliplatin chemoresistance in EpCAMhigh/CD44+ colorectal cancer stem cells
by: Qi Yanmei, et al.
Published: (2022-07-01)